NDC 0002-1495-80
Mounjaro 5 mg/.5mL
tirzepatide · INJECTION, SOLUTION
Mounjaro (tirzepatide) is a prescription injection used to treat type 2 diabetes by helping your body better control blood sugar levels. It belongs to a class of medications that work by stimulating insulin release in response to glucose.
Key Facts
- Brand Name
- Mounjaro
- Generic Name
- tirzepatide
- NDC Code (Package)
0002-1495-80- NDC Code (Product)
0002-1495- Manufacturer
- Eli Lilly and Company
- Strength
- 5 mg/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA215866
- Drug Class
- Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]; GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 05/13/2022
Recall History
No Recall HistoryView Full Drug Page
Mounjaro — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.